Calls Sold on Salix Pharma (SLNX)

Shares of Salix Pharmaceuticals Inc. SLNX are higher on the session by 0.35%, currently trading at $42.89. The stock has been moving largely higher over the past six months and is trading just off of its 52-week high set just two days ago. Options traders are selling calls on the name today. The August $44.00 call was sold 1,000 times, on or near the bid, earlier in the session; open interest on the strike is only 965 contracts. This appears to be a covered call trade. Call volume is now running at 2.4x the daily average. Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract.